Rankings
▼
Calendar
PMVP FY 2023 Earnings — PMV Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
PMVP
PMV Pharmaceuticals, Inc.
$88M
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$1M
Operating Income
-$80M
Net Income
-$69M
EPS (Diluted)
$-1.44
Cash Flow
Operating Cash Flow
-$56M
Free Cash Flow
-$57M
Stock-Based Comp.
$12M
Balance Sheet
Total Assets
$252M
Total Liabilities
$26M
Stockholders' Equity
$226M
Cash & Equivalents
$38M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$1M
-$650,000
-93.4%
Operating Income
-$80M
-$77M
-4.0%
Net Income
-$69M
-$73M
+5.9%
← Q4 2022
All Quarters
Q1 2023 →